Your browser doesn't support javascript.
loading
Screening for the C9ORF72 expansion in Greek Huntington Disease phenocopies and controls and meta-analysis of current data.
Rikos, Dimitrios; Marogianni, Chrysoula; Provatas, Antonios; Bourinaris, Thomas; Arnaoutoglou, Marianthi; Stathis, Pantelis; Patrinos, George P; Dardiotis, Efthimios; Hadjigeorgiou, George M; Xiromerisiou, Georgia.
Afiliação
  • Rikos D; University of Thessaly, University Hospital of Larissa, Neurology Department, Larissa, GR.
  • Marogianni C; University of Thessaly, University Hospital of Larissa, Neurology Department, Larissa, GR.
  • Provatas A; University of Thessaly, University Hospital of Larissa, Neurology Department, Larissa, GR.
  • Bourinaris T; Department of Molecular Neuroscience Institute of Neurology, University College London, London, UK.
  • Arnaoutoglou M; First Neurology Clinic, AHEPA Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, GR.
  • Stathis P; Department of Neurology, Mediterraneo Hospital, Athens, GR.
  • Patrinos GP; University of Patras School of Health Sciences, Department of Pharmacy, Patras, GR.
  • Dardiotis E; United Arab Emirates University, College of Medicine and Health Sciences, Department of Pathology, Al-Ain, AE.
  • Hadjigeorgiou GM; United Arab Emirates University, Zayed Center of Health Sciences, Al-Ain, AE.
  • Xiromerisiou G; University of Thessaly, University Hospital of Larissa, Neurology Department, Larissa, GR.
Article em En | MEDLINE | ID: mdl-32775019
ABSTRACT

Background:

Several European studies examined the role of C9orf72 repeat expansion in patients with Huntington-disease like phenotypes (HD-L). The scope of our study is to investigate the expansion frequency in a Greek HD-L cohort and the meta-analysis of all published cases. This will be of use in genetic counseling of these cases.

Methods:

A cohort of 74 patients with HD-L and 67 healthy controls were screened for the C9orf72 expansion status. Case-controls comparison was assessed with the Pearson's chi-square statistic for a 2 × 2 table.A systematic database search was conducted and seven studies, including the current study, were considered eligible for inclusion in a meta-analysis considering a total of 812 patients with HD phenocopies. Pooled mutation frequency was calculated using a Random Effects model or the Mantel-Haezsel fixed effects model, depending on the observed heterogeneity.

Results:

In our cohort, one patient was found to have a pathologic expansion of C9orf72, and none from the control group (chi-square 0.91, p-value 0.34). Pooled mutation frequency was found at 2% (CI 1-3%) with low heterogeneity (I215%).

Discussion:

Based on this meta-analysis the recommendation for genetic testing for C9orf72 expansions is further solidified.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Heredodegenerativos do Sistema Nervoso / Proteína C9orf72 Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Heredodegenerativos do Sistema Nervoso / Proteína C9orf72 Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article